Transposagen Biopharmaceuticals
Transposagen Biopharmaceuticals, Inc. based in Lexington, KY has announced that its Vice President of Research, Dr. Blair Madison has received the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (NIH) for a project he designed on mobile element mutagenesis. The NIH’s primary objective of this award is to help ensure that diverse pools of highly trained scientists will be available in adequate numbers and in appropriate research areas to carry out the nation’s biomedical, behavioral and clinical research agendas. Awards are given for up to a three year research period.
“I am honored to receive this award from the NIH,” said Dr. Madison. “This award will provide an invaluable opportunity to investigate the molecular genetic causes of colon cancer.”
Dr. Madison’s research has enabled Transposagen to expand upon its breakthrough technology by designing a new method of mutagenesis using mobile DNA elements (or “jumping genes”) for the rapid identification of cancer genes. “This method will enable the rapid discovery of oncogenes and tumor suppressors that are directly linked to cancer initiation and progression,”
Photo:
http://www.prlog.org/
